Results 101 to 110 of about 48,916 (295)
Epilepsia Open, EarlyView.Abstract The SCN1A gene is implicated in a broad spectrum of epilepsy phenotypes, ranging from self‐limited genetic epilepsy with febrile seizures plus (GEFS+) to severe developmental and epileptic encephalopathies such as Dravet syndrome (DS). While fenfluramine (FFA) has demonstrated strong efficacy in DS, its role in SCN1A‐related epilepsies beyond ...
Giovanni B. Dell'Isola +12 more
wiley +1 more source
STUDI POTENSI KORIDOR DI APARTEMEN CBD SURABAYA MENJADI RUANG SOSIAL ANAK
, 2022 Stanley Odwin +2 more
openalex +2 more sources
Highly purified cannabidiol (CBD) in CDKL5 deficiency disorder (CDD): Open‐label prospective study
Epilepsia Open, EarlyView.Abstract Objective CDKL5 deficiency disorder (CDD) is an early‐onset developmental and epileptic encephalopathy characterized by frequent drug‐resistant seizures, cerebral visual impairment, motor dysfunction, and sleep and gastrointestinal disturbances.
Marco Perulli +12 more
wiley +1 more source
Efficacy of neurosurgical interventions for epilepsy in polymicrogyria: A systematic review
Epilepsia Open, EarlyView.Abstract Polymicrogyria (PMG) is a rare malformation of cortical development (MCD) characterized by abnormal neuronal architecture, often associated with epilepsy. Neurosurgical interventions have been explored, but their effectiveness remains a subject of ongoing research and debate.
Sergio Rinella +4 more
wiley +1 more source
Role of copper in type 2 Diabetes Mellitus: A mini-review [PDF]
Journal of Stress Physiology & BiochemistryDiabetes Mellitus (DM) presents a significant global health challenge, with escalating prevalence rates and associated morbidity and mortality. Despite medical advancements, the mortality rates continue to rise, necessitating a deeper understanding of ...
Varsha Shirur +4 more
doaj
Epilepsia Open, EarlyView.Abstract Objective Ketogenic dietary therapies (KDTs) are the treatment of choice for Glut1 Deficiency Syndrome (Glut1DS), providing dietary ketones as an alternative fuel to the brain and effectively controlling seizures. Recent evidence indicates insufficient seizure control in Glut1DS patients despite adequate KDT and ketosis.
Joerg Klepper, Eva Runkel, Lucia Kiesel
wiley +1 more source
[RETRACTED] SAFE TO USE:- ORGANIXX CBD GUMMIES (SHAR TANK UPDATED 2022) v1
, 2022 Flora B. Garcia
openalex +1 more source
Epilepsia Open, EarlyView.Abstract Objectives Dravet syndrome (DS) is a drug‐resistant developmental and epileptic encephalopathy, often requiring three or more antiseizure medications (ASMs). Consequently, the therapeutic landscape is highly complex, combining DS‐specific agents (stiripentol, STP; cannabidiol, CBD; fenfluramine, FFA), non‐specific ASMs, and non‐pharmacologic ...
J. Helen Cross +4 more
wiley +1 more source